Ropharma Sa (0NZQ)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
総売上 | 509.83M | 534.78M | 636.83M | 722.82M | 721.21M | 779.63M | 916.25M | 1.12B |
営業利益 | 13.04M | 13.43M | 11.88M | 9.13M | 15.62M | 18.58M | 10.38M | 18.06M |
税引前収入 | 12.89M | 15.21M | 14.76M | 6.69M | 6.64M | 13.53M | 10.32M | 13.69M |
純利益 | 10.35M | 11.63M | 12.12M | 7.52M | 6.75M | 10.73M | 9.22M | 7.72M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0.02 | 0.023 | 0.024 | 0.015 | 0.013 | 0.021 | 0.018 | 0.015 |
EBIT | 12.86M | 13.22M | 11.64M | 8.83M | 14.86M | 18.58M | 10.15M | 18.03M |
EBITDA | 22.01M | 22.41M | 21.52M | 27.84M | 38.31M | 41.73M | 34.17M | 44.71M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約